COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic cancers. Patients resistant to prior immunotherapy showed the most benefit ...

The COVID-19 virus may have the surprising ability to shrink some tumors, paving the way for new cancer treatments, a new study has found. The research, conducted at the Northwestern Medicine Canning ...

In patients with AF and COVID-19 who receive DOAC, 30-day mortality risk is similar for nirmatrelvir/ritonavir and RdRp inhibitors.

Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

Add Yahoo as a preferred source to see more of our stories on Google. Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern Medicine ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus’s own replication machinery to switch on reporter or therapeutic genes precisely in infected cells.

Some COVID-19 patients are testing positive after recovering in Asia, but experts say the presence of antibodies should guarantee short-term immunity ...